Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Sensorineural Hearing Loss”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05788536
What this trial is testing

DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

Who this might be right for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Regeneron Pharmaceuticals 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06370351
What this trial is testing

A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

Who this might be right for
OTOF Gene MutationDFNB9Congenital Deafness+5 more
Sensorion 12
Not applicableLooking for participantsNCT05355415
What this trial is testing

Adaptive Optics Imaging of Outer Retinal Diseases

Who this might be right for
Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more
Food and Drug Administration (FDA) 100
Not applicableStudy completedNCT00231010
What this trial is testing

Molecular Genetics of Retinal Degenerations

Who this might be right for
Retinal DegenerationRetinitis Pigmentosa
National Eye Institute (NEI) 3,549
Large-scale testing (Phase 3)Study completedNCT02005822
What this trial is testing

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment

Who this might be right for
Congenital Cytomegalovirus InfectionSensorineural Hearing Loss
Dr. Ann C.T.M. Vossen 37
Not applicableLooking for participantsNCT04665726
What this trial is testing

Natural History Study of Usher Syndrome ( Light4Deaf )

Who this might be right for
Usher Syndromes
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 400
Testing effectiveness (Phase 2)Study completedNCT03780257
What this trial is testing

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
ProQR Therapeutics 20
Not applicableLooking for participantsNCT06722170
What this trial is testing

EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss

Who this might be right for
DFNB9Congenital Hearing LossHearing Loss, Sensorineural
Yilai Shu 24
Testing effectiveness (Phase 2)Study completedNCT02497690
What this trial is testing

Effectiveness of Therapy Via Telemedicine Following Cochlear Implants

Who this might be right for
Congenital Sensorineural Deafness
University of Colorado, Denver 77
Not applicableUnknownNCT01954953
What this trial is testing

Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe

Who this might be right for
Usher Syndrome
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 100
Not applicableLooking for participantsNCT06226558
What this trial is testing

Long-Term Outcomes of Children With Congenital CMV in New York State

Who this might be right for
Congenital CMV InfectionSensorineural Hearing Loss
Stony Brook University 1,000
Not applicableLooking for participantsNCT07635368
What this trial is testing

Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection

Who this might be right for
Congenital CytomegalovirusCytomegalovirus InfectionsNeonatal Infection+2 more
Rigshospitalet, Denmark 630
Testing effectiveness (Phase 2)Study completedNCT01530659
What this trial is testing

Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Usher Syndrome Type 3
Neurotech Pharmaceuticals 22
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Looking for participantsNCT06591793
What this trial is testing

Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Who this might be right for
Usher Syndrome, Type 1B
AAVantgarde Bio Srl 15